X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

ENDOCRINE-RELATED CANCER

期刊標題檢索 ENDOCR-RELAT CA 最新評論: There is no specific editor in mind. (2024-08-07)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[ENDOCRINE-RELATED CANCER]您好,您是該頁面的第 29164 位訪客。

期刊簡介
期刊名稱ENDOCRINE-RELATED CANCER ENDOCRINE-RELATED CANCER
LetPub Score
7.4
50 ratings
Rate

Reputation
8.8

Influence
6.5

Speed
7.0

期刊簡稱ENDOCR-RELAT CANCER
ISSN1351-0088
E-ISSN1479-6821
h-index119
CiteScore
CiteScoreSJRSNIPCiteScore Rank
7.801.3310.953
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Oncology
Q185 / 404
Category: Medicine
Subcategory: Endocrinology, Diabetes and Metabolism
Q152 / 244
Category: Medicine
Subcategory: Endocrinology
Q233 / 128
Category: Medicine
Subcategory: Cancer Research
Q276 / 230

自引率 (2023-2024)2.40%自引率趨勢
掲載範囲
Endocrine-Related Cancer is an official flagship journal of the Society for Endocrinology and is endorsed by the European Society of Endocrinology, the United Kingdom and Ireland Neuroendocrine Society, and the Japanese Hormones and Cancer Society.

Endocrine-Related Cancer provides a unique international forum for the publication of high quality original articles describing novel, cutting edge basic laboratory, translational and clinical investigations of human health and disease focusing on endocrine neoplasias and hormone-dependent cancers; and for the publication of authoritative review articles in these topics.

Endocrine neoplasias include adrenal cortex, breast, multiple endocrine neoplasia, neuroendocrine tumours, ovary, prostate, paraganglioma, parathyroid, pheochromocytoma pituitary, testes, thyroid and hormone-dependent cancers. Neoplasias affecting metabolism and energy production such as bladder, bone, kidney, lung, and head and neck, are also considered.
官方網站http://erc.endocrinology-journals.org/
在線稿件提交http://www.endocrinology-journals.org/site/misc/submit-online.xhtml
開放訪問No
出版商BioScientifica Ltd.
主題領域医学
出版國/地區ENGLAND
發行頻率四半期刊行
創刊年1994
每年文章數115每年文章數趨勢
黃金OA百分比17.48%
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
ENDOCRINOLOGY & METABOLISMSCIEQ249/186
ONCOLOGYSCIEQ291/322
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1351-0088%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Slow, 6-12 Week(s)
競爭力 *來自作者的數據: Ordinary
參考鏈接
相關期刊 【ENDOCRINE-RELATED CANCER】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Nature Reviews EndocrinologyH-index: 116

    CiteScore: 42.00
    Cell MetabolismH-index: 219

    CiteScore: 48.60
    ENDOCRINE REVIEWSH-index: 257

    CiteScore: 42.00
    DIABETES CAREH-index: 328

    CiteScore: 29.50
    TRENDS IN ENDOCRINOLOGY AND METABOLISMH-index: 146

    CiteScore: 20.10
    METABOLISM-CLINICAL AND EXPERIMENTALH-index: 122

    CiteScore: 18.90
    Cardiovascular DiabetologyH-index: 64

    CiteScore: 12.30
    DIABETOLOGIAH-index: 207

    CiteScore: 18.10
    JOURNAL OF PINEAL RESEARCHH-index: 113

    CiteScore: 17.70
    Obesity ReviewsH-index: 137

    CiteScore: 19.30
    學科內最受檢索的期刊 頁面查看次數
    FREE RADICAL BIOLOGY AND MEDICINE191720
    Cell Metabolism129848
    DIABETES101916
    JOURNAL OF PINEAL RESEARCH98165
    BIOLOGICAL TRACE ELEMENT RESEARCH92859
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM81290
    ANTIOXIDANTS & REDOX SIGNALING79914
    DIABETES CARE73455
    BONE70437
    Obesity68338
  •  

    ENDOCRINE-RELATED CANCER ENDOCRINE-RELATED CANCER
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [ENDOCRINE-RELATED CANCER] 的評論撰寫評論
作者: 宁蒙氏


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-07 22:04:03 評論於
There is no specific editor in mind.
(0) 讚! | 宁蒙氏

作者: 云来俊贤


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-05 15:06:27 評論於
Could you please tell me if the SchoolOne system will display the ADM's name? Mine only shows "under review" but does not display any editing options.
(0) 讚! | 云来俊贤

作者: 宁蒙氏


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-21 18:14:29 評論於
Research focus: Thyroid tumors
Experience sharing: Submitted one article, reviewed by two reviewers, review process took about 3 months, accepted within 1 month after revisions. Editors and reviewers are responsible, emails inquiries are all responded to. The overall process takes about 4-5 months, urgent submissions may be temporarily suspended. The annual submission volume is small, OA mode is now available, pound sterling is the most cost-effective, about 28,000 RMB, receive first proof within 1 month, published in the 2nd or 3rd issue after acceptance
(0) 讚! | 宁蒙氏

作者: 拂柳孟州


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-04-09 23:13:36 評論於
Review speed: 2.0 | Submission acceptance rate: 75.0 Focus research areas: Bioinformatics Experience sharing: None
(0) 讚! | 拂柳孟州

作者: 北斗冰双


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-02-18 12:03:06 評論於
Excuse me, does this magazine accept articles on bioinformatics and experiments? Do I need to provide original data and Western blotting membranes?
(0) 讚! | 北斗冰双

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 17:45:54 評論於
1. Theme: Submission Section, Article Title, Published Pen Name. Content: The full content of the article.
2. Author information is included after the main text. Author information includes: your real contact address, postal code, name, email address, landline phone, cell phone, QQ number (with QQ name specified), and any other necessary contact information (such as a brief bio
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 15:18:41 評論於
After the reviewer completes the scoring of the chapter, they need to write a complete review opinion. This usually includes a brief summary of the content of the article, evaluation of the innovative points of the article, pointing out the shortcomings of the article, and giving advice on how the editor should handle the article
(0) 讚! | 维尔娜菲茨杰拉德

作者: 深渊兴业


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-28 13:59:32 評論於
What aspects should be paid attention to in the letters sent by journals?
(0) 讚! | 深渊兴业

作者: 八坂篷蔚


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 20:04:05 評論於
What are the opinions and suggestions of journal editors? What are the opinions and suggestions of reviewers? What are the differences between the two?
(0) 讚! | 八坂篷蔚

作者: 仲夏颖初


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-11-11 10:43:32 評論於
Review speed: 2.0 | Submission acceptance rate: 25.0
Experience sharing: ENDOCR-RELAT CANCER is a top journal in the field of endocrinology and metabolism, with high submission difficulty and quality articles
(0) 讚! | 仲夏颖初

作者: 华美小可爱


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-02-07 09:11:47 評論於
I also rejected it in seconds, maybe not friendly to Chinese people
(0) 讚! | 华美小可爱

作者: 魔都惜香


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-01-06 12:59:35 評論於
Can you give me some advice? Why am I being rejected so quickly?
(0) 讚! | 魔都惜香

作者: 新荣mio


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-07-17 16:16:21 評論於
Try the feeling of wanting to be instantly rejected here for a few seconds haha
(0) 讚! | 新荣mio

作者: 四风文雅


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-05-06 08:01:26 評論於
Submission Hit Rate: 5.0. Sharing experience: If you want to experience the feeling of being instantly rejected, try submitting here, O(∩_∩)O haha~
(0) 讚! | 四风文雅

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-07-16 10:09:28 評論於
Passing the 5-point mark is a cause for celebration. To reach the next level next year with 6 points would be even more remarkable
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2013-08-29 18:46:20 評論於
Review speed: 3.0 | Submission acceptance rate: 25.0
Experience sharing: Just submitted a paper to a top journal in the field, with the latest IF value rising to 5.261! The journal focuses on rigorous basic research. If you have a strong design and a complete story, it is worth submitting!
(0) 讚! | 凌霄高洁

作者: 匿名


領域:
審稿時間: 0.0 month(s)
結果:


撰寫評論

2013-04-02 10:12:00 評論於
This journal is published or managed by the Society for Endocrinology. Be careful with the scope of the papers it accepts.

(1) 讚! | 匿名

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [ENDOCRINE-RELATED CANCER] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*